作者
Julio A Chirinos, Jordana B Cohen, Lei Zhao, Thomas Hanff, Nancy Sweitzer, James Fang, Vicente Corrales-Medina, Ron Ammar, Michael Morley, Payman Zamani, Priyanka Bhattacharya, Jeff Brandimarto, Yi Jia, Michael D Basso, Zhaoqing Wang, Christina Ebert, Francisco Ramirez-Valle, Peter H Schafer, Dietmar Seiffert, David A Gordon, Thomas Cappola
发表日期
2020/11
期刊
Hypertension
卷号
76
期号
5
页码范围
1526-1536
出版商
Lippincott Williams & Wilkins
简介
ACE2 (angiotensin-converting enzyme 2) is a key component of the renin-angiotensin-aldosterone system. Yet, little is known about the clinical and biologic correlates of circulating ACE2 levels in humans. We assessed the clinical and proteomic correlates of plasma (soluble) ACE2 protein levels in human heart failure. We measured plasma ACE2 using a modified aptamer assay among PHFS (Penn Heart Failure Study) participants (n=2248). We performed an association study of ACE2 against ≈5000 other plasma proteins measured with the SomaScan platform. Plasma ACE2 was not associated with ACE inhibitor and angiotensin-receptor blocker use. Plasma ACE2 was associated with older age, male sex, diabetes mellitus, a lower estimated glomerular filtration rate, worse New York Heart Association class, a history of coronary artery bypass surgery, and higher pro-BNP (pro-B-type natriuretic peptide) levels …
引用总数
2020202120222023202421316133